Matthew L. Trerotola serves as the Chief Executive Officer at ENOVIS CORP, a global medical technology company focused on developing innovative solutions for orthopedic and reconstructive surgery. Prior to joining ENOVIS, Trerotola held several high-profile leadership positions in the healthcare and medical technology sectors. He previously served as the CEO of RESMED, a leading provider of medical equipment for the treatment of sleep-disordered breathing, where he played a pivotal role in expanding the company's global presence and driving significant revenue growth. Trerotola's professional journey in the healthcare industry spans over two decades, during which he has demonstrated a strong track record of strategic leadership and operational excellence. Before his tenure at RESMED, he held executive positions at companies such as Baxter International and General Electric Healthcare, where he was instrumental in developing and executing growth strategies that enhanced market share and profitability. His expertise in driving innovation and fostering a culture of continuous improvement has been a key factor in his success across these organizations. As CEO of ENOVIS CORP, Trerotola is responsible for overseeing the company's overall strategy and operations, with a focus on accelerating growth and enhancing shareholder value. Under his leadership, ENOVIS has made significant investments in research and development, aiming to bring cutting-edge orthopedic solutions to market. Trerotola's vision for the company includes expanding its product portfolio and strengthening its position as a leader in the medical technology industry. His commitment to excellence and innovation continues to drive ENOVIS forward, positioning the company for long-term success.